Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
- 20 May 2002
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 31 (2), 133-134
- https://doi.org/10.1038/ng888
Abstract
We found that PPM1D, encoding a serine/threonine protein phosphatase, lies within an epicenter of the region at 17q23 that is amplified in breast cancer. We show that overexpression of this gene confers two oncogenic phenotypes on cells in culture: attenuation of apoptosis induced by serum starvation and transformation of primary cells in cooperation with RAS.Keywords
This publication has 14 references indexed in Scilit:
- Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityNature Genetics, 2002
- Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancerProceedings of the National Academy of Sciences, 2001
- Oncogenic kinase signallingNature, 2001
- Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomasCancer Genetics and Cytogenetics, 2001
- p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiationThe EMBO Journal, 2000
- Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancersNature Genetics, 2000
- Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray AnalysisJNCI Journal of the National Cancer Institute, 2000
- Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarraysNature Genetics, 1999
- Oncogene amplification in solid tumorsSeminars in Cancer Biology, 1999
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997